ConductScience.org, home

Paper728896

Effect of thymosin and irradiation on immune modulation in head and neck and esophageal cancer patients.

Wara WM and 2 others. Cancer Treat Rep, 1978. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Effect of thymosin and irradiation on immune modulation in head and neck and esophageal cancer patients. Papers, record 728896. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/728896

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of thymosin and irradiation on immune modulation in head and neck and esophageal cancer patients.
PubMed
Journal
Cancer Treat Rep
PubMed
Year
1978
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.59
iCite
Revised in PubMed
2021-12-03
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wara WMW M
2Ammann AJA J
3Wara DWD W

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
Esophageal NeoplasmsMajor topic
Head and Neck NeoplasmsMajor topic
ImmunityMajor topic
ThymosinMajor topic
Thymus HormonesMajor topic
Female
Humans
Immunosuppression Therapy
Lymphocytes
Male

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06139419The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLCBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
39155831Alpha/beta-defensins influence on the humoral immunity and complications in cancer of the oral cavity and oropharynx.Immunotherapy2024https://conductscience.org/library/papers/39155831PubMed
30221039Stereotactic body radiation therapy and thymosin alpha-1-induced anti-tumor effects in heavily pretreated, metastatic esophageal squamous cell carcinoma patients.Oncoimmunology2018https://conductscience.org/library/papers/30221039PubMed
25320012Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer.Cancer Res2014https://conductscience.org/library/papers/25320012PubMed
6478652Experimental autoimmune thyroiditis: modulation of the disease level in high and low responder mice by thymosin.Clin Exp Immunol1984https://conductscience.org/library/papers/6478652PubMed
3157439The effects of thymic epithelial monolayer-conditioned medium on suppressor cell function following chemotherapy in pediatric patients.Cancer Immunol Immunother1985https://conductscience.org/library/papers/3157439PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/728896

GET https://conductscience.org/api/papers/v1/728896/authors